U.S. Department Of Defense selects Applied Biosystems for development of instrument system to identify infectious diseases
The current technologies that are used to test for infectious pathogens typically reside in a centralized laboratory environment. By successfully developing a prototype system that simplifies the processing and analysis of pathogen detection tests, Applied Biosystems expects to enable a new generation of decentralized molecular detection systems that can be deployed in more diverse locations and operated by a broader range of public health and safety professionals. These new systems are also expected to introduce a more flexible, modular design that will allow for the rapid customization of new test panels - or assays - that can detect emerging pathogens.
Early prototypes have demonstrated the ability to identify up to 10 pathogens simultaneously on a test array that is the size of a credit card. Through parallel analysis of multiple gene targets, these systems are expected to provide more detailed information about the nature of each sample being tested. Such modular systems may have future applications in other areas of biosecurity as well as in forensics, animal testing and food quality testing.
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.